(Q46829240)
Statements
1 reference
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation (English)
1 reference
Comenzo RL
1 reference
Hassoun H
1 reference
Kewalramani T
1 reference
Klimek V
1 reference
Dhodapkar M
1 reference
Reich L
1 reference
Teruya-Feldstein J
1 reference
Fleisher M
1 reference
Filippa D
1 reference
Nimer SD
1 reference
1 February 2006
1 reference
1 reference
20
1 reference
2
1 reference
345-349
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference